| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00296-019-04437-Y |
| P698 | PubMed publication ID | 31520109 |
| P50 | author | Bilal Toka | Q90101803 |
| Emel Gönüllü | Q90101808 | ||
| Mukaddes Tozlu | Q90101811 | ||
| Mustafa Ihsan Uslan | Q90101814 | ||
| Aydin Seref Koksal | Q90101820 | ||
| Oğuz Karabay | Q42930171 | ||
| Erkan Parlak | Q49092857 | ||
| Ahmet T Eminler | Q88357814 | ||
| P2860 | cites work | Medical interventions associated with HBV reactivation: Common and less common | Q91655790 |
| Prevention of Hepatitis B reactivation in the setting of immunosuppression | Q26747023 | ||
| EASL clinical practice guidelines: Management of chronic hepatitis B virus infection | Q29615868 | ||
| Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. | Q30391932 | ||
| Antiviral treatment of chronic hepatitis B virus (HBV) infections | Q34223779 | ||
| American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. | Q34782898 | ||
| Current hepatitis B screening practices and clinical experience of reactivation in patients undergoing chemotherapy for solid tumors: a nationwide survey of medical oncologists | Q34974883 | ||
| Poor recognition of risk factors for hepatitis B by physicians prescribing immunosuppressive therapy: a call for universal rather than risk-based screening | Q35429416 | ||
| Hepatitis B reactivation in the setting of chemotherapy and immunosuppression - prevention is better than cure | Q35567748 | ||
| Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update | Q35706189 | ||
| Outcomes of the implementation of the computer-assisted HBView system for the prevention of hepatitis B virus reactivation in chemotherapy patients: a retrospective analysis | Q36508888 | ||
| Reactivation of hepatitis B. | Q37462566 | ||
| Hepatitis B virus reactivation in HBsAg-positive patients with rheumatic diseases undergoing anti-tumor necrosis factor therapy or DMARDs | Q38155954 | ||
| Systemic diseases and biotherapies: understanding, evaluating, and preventing the risk of hepatitis B reactivation | Q38190322 | ||
| American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy. | Q38275215 | ||
| Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure. | Q38351585 | ||
| Hepatitis B Virus Reactivation and Prophylaxis During Solid Tumor Chemotherapy: A Systematic Review and Meta-analysis. | Q38643394 | ||
| Hepatitis B virus reactivation in patients with solid tumors receiving systemic anticancer treatment | Q38996149 | ||
| Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study | Q40295481 | ||
| Computerized physician order entry-based system to prevent HBV reactivation in patients treated with biologic agents: the PRESCRIB project | Q42234350 | ||
| Oncologists and hepatitis B: a survey to determine current level of awareness and practice of antiviral prophylaxis to prevent reactivation | Q43598802 | ||
| Dermatologists' awareness of and screening practices for hepatitis B virus infection before initiating tumor necrosis factor-α inhibitor therapy | Q45361701 | ||
| Prevalence of reactivation of hepatitis B virus replication in rheumatoid arthritis patients | Q45374140 | ||
| American Society of Clinical Oncology provisional clinical opinion: chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseases | Q45375628 | ||
| Rheumatologists' awareness of and screening practices for hepatitis B virus infection prior to initiating immunomodulatory therapy | Q45376062 | ||
| A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: a randomized trial | Q46732231 | ||
| Update on Prevention, Diagnosis, and Treatment and of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance | Q50190669 | ||
| 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis | Q57245378 | ||
| Screening for hepatitis B in chemotherapy patients: survey of current oncology practices | Q84674541 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 2077-2085 | |
| P577 | publication date | 2019-09-13 | |
| P1433 | published in | Rheumatology International | Q15763689 |
| P1476 | title | Rheumatologists' awareness of hepatitis B reactivation before immunosuppressive therapy | |
| P478 | volume | 39 |
Search more.